Loading stock…

Henry Schein, Inc. (HSIC) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Henry Schein, Inc.

HSICMarket cap $9.46BPrice $84.8

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

Supplies dentists and doctors with everything from gloves to X-ray machines, quietly running the world's largest dental products distribution network. Practices in over 100 countries depend on it just to open their doors each morning.

In Bastion Portfolios?

52W Return+35%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+1%3

Revenue Forecast

Rev CAGR (1y)+5%4

Rev CAGR (3y)+4%3

Rev CAGR (5y)+4%4

Earnings Forecast

EPS Growth Y+1+67%10

EPS Growth Y+2+10%6

EPS Growth Y+3+8%6

Quality

Margins

EBIT Margin6%3

Net Income Margin3%3

Free Cash Flow Margin4%4

Debt

Net Debt/EBITDA3.13

Efficiency

ROE12%5

ROA4%5

Earnings Stability44

GEAR+AVERAGE36

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)156

P/E Ratio (Forward 3y)136

P/BV3.05

EV Multiples

EV/EBITDA Fwd125

EV/EBIT Fwd146

Yield

Free Cash Flow Yield6.0%7

Dividend Yieldna–

Momentum

Short term

1 month return-6%4

3 month return-2%6

YTD return+12%7

Mid term

Price vs 52wHigh92%9

1 year return+31%8

Long term

3 year return+14%3

5 year return+6%4

Risk Shield

Price Risk

Beta0.39

Volatility25%8

Free Cash Flow

Free Cash Flow Margin4%4

Free Cash Flow Yield6.0%7

Quality

ROCE10%6

Earnings Stability44

Net Debt/EBITDA3.13

02Growth

Is it actually growing, and how fast?

HSICHenry Schein

Revenue FY25$13.2B

GROWTH RATING↗

WEAK31 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+1%3

Revenue, next 1Y+5%4

Revenue, next 3Y, CAGR+4%3

Revenue, next 5Y, CAGR+4%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+67%10

EPS growth, FY27E+10%6

EPS growth, FY28E+8%6

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 1%/yr over the last 3 years and is set to grow 4%/yr from here.

Earnings are set to grow faster than sales (EPS about 10%/yr vs revenue 4%/yr), so margins should widen.

WATCH

Revenue is set to grow 4%/yr over the next 3 years, a little behind the market.4/10

Over five years revenue is set to grow 4%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

Growth is the weak spot here, trailing 69% of companies worldwide.

Revenue grew 1%/yr over the last 3 years, behind 70% of companies worldwide.3/10

BOTTOM LINE

Margin Expander

Growth is a weak point here: a business that's speeding up. The one thing to watch: the 3-year revenue record is weak.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE55 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return-2%6

YTD return+12%7

MID & LONG-TERM▾SCORE

% of 52-week high92%9

1-year return+31%8

3-year return+14%3

5-year return+6%4

MOMENTUM ASSESSMENT

STRENGTHS

It's up 31% over the past year, now 8% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming so far this year (+12%).

WATCH

Returns sit at the market level over the past month (-6%) and over three months (-2%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+14% over three years and +6.4% over five), behind 60% of the market.

BOTTOM LINE

Mixed Momentum

Horizons disagree or sit near the middle of the pack. Momentum investors may want a clearer trend before sizing up. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Schein. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

HSICHenry Schein

Revenue FY25$13.2B

GROWTH RATING↗

WEAK31 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+1%3

Revenue, next 1Y+5%4

Revenue, next 3Y, CAGR+4%3

Revenue, next 5Y, CAGR+4%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+67%10

EPS growth, FY27E+10%6

EPS growth, FY28E+8%6

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 1%/yr over the last 3 years and is set to grow 4%/yr from here.

Earnings are set to grow faster than sales (EPS about 10%/yr vs revenue 4%/yr), so margins should widen.

WATCH

Revenue is set to grow 4%/yr over the next 3 years, a little behind the market.4/10

Over five years revenue is set to grow 4%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

Growth is the weak spot here, trailing 69% of companies worldwide.

Revenue grew 1%/yr over the last 3 years, behind 70% of companies worldwide.3/10

BOTTOM LINE

Margin Expander

Growth is a weak point here: a business that's speeding up. The one thing to watch: the 3-year revenue record is weak.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE55 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-6%4

3-month return-2%6

YTD return+12%7

MID & LONG-TERM▾SCORE

% of 52-week high92%9

1-year return+31%8

3-year return+14%3

5-year return+6%4

MOMENTUM ASSESSMENT

STRENGTHS

It's up 31% over the past year, now 8% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming so far this year (+12%).

WATCH

Returns sit at the market level over the past month (-6%) and over three months (-2%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+14% over three years and +6.4% over five), behind 60% of the market.

BOTTOM LINE

Mixed Momentum

Horizons disagree or sit near the middle of the pack. Momentum investors may want a clearer trend before sizing up. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Schein. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community